Last update 21 Nov 2024

SLF-1081851

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target
SPNS2
Mechanism
SPNS2 inhibitors(sphingolipid transporter 2 inhibitors)
Therapeutic Areas
Immune System DiseasesNervous System DiseasesDigestive System Disorders+ [2]
Active Indication
Colitis, UlcerativeMultiple SclerosisKidney Diseases
Inactive Indication-
Originator Organization
Virginia Tech Corporate Research Center, Inc.Virginia Tech Corporate Research Center, Inc.
Active Organization
Virginia Tech Corporate Research Center, Inc.Virginia Tech Corporate Research Center, Inc.University of VirginiaUniversity of VirginiaUniversity of TokyoUniversity of Tokyo
Inactive Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Structure

Molecular FormulaC21H34ClN3O
InChIKeyZJJXKBLUUGLWDW-UHFFFAOYSA-N
CAS Registry2999629-35-3

Related

100 Clinical Results associated with SLF-1081851
Login to view more data
100 Translational Medicine associated with SLF-1081851
Login to view more data
100 Patents (Medical) associated with SLF-1081851
Login to view more data
1
Literatures (Medical) associated with SLF-1081851
01 Nov 2023Bioorganic & Medicinal Chemistry Letters
Imidazole-based sphingosine-1-phosphate transporter Spns2 inhibitors
100 Deals associated with SLF-1081851
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Colitis, UlcerativePreclinical
US
Virginia Tech Corporate Research Center, Inc.Virginia Tech Corporate Research Center, Inc.
02 Jul 2024
Multiple SclerosisPreclinical
US
Virginia Tech Corporate Research Center, Inc.Virginia Tech Corporate Research Center, Inc.
02 Jul 2024
Kidney DiseasesPreclinical
JP
University of TokyoUniversity of Tokyo
16 Aug 2022
Kidney DiseasesPreclinical
US
University of VirginiaUniversity of Virginia
16 Aug 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free